Could Drug Delivery Systems Be Enhancers for Therapy against KRAS-driven Cancers?

RR Khusnutdinov - Reviews and Advances in Chemistry, 2025‏ - Springer
KRAS (Kirsten rat sarcoma viral oncogene homologue) is the most frequently mutated gene
in the RAS superfamily, involved in up to 85% of all RAS-driven cancers according to …

LIPID NANOPARTICLES ALLOW INTRACELLULAR PROTEIN DELIVERY FOR MODULATION OF DIFFICULT THERAPEUTIC TARGETS

R Haley - 2024‏ - repository.upenn.edu
Small molecule and nucleic acid-based therapies have a wide variety of powerful clinical
applications, but in the case of certain identified targets, protein biologics may be a …